Bentham Science Logo

Track Your Manuscript:

Current Pharmaceutical Design

Volume 28, 46 Issues, 2022
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access


Current Pharmaceutical Design , Volume 18 - Number 4

Basic Symptoms and the Prediction of First-Episode Psychosis

, 18(4): 351 - 357

Frauke Schultze-Lutter, Stephan Ruhrmann, Paolo Fusar-Poli, Andreas Bechdolf, Benno G. Schimmelmann and Joachim Klosterkotter

DOI: 10.2174/138161212799316064

Rationale and First Results of Developing At-Risk (Prodromal) Criteria for Bipolar Disorder

, 18(4): 358 - 375

A. Bechdolf, A. Ratheesh, S. J. Wood, T. Tecic, P. Conus, B. Nelson, S. M. Cotton, A. M. Chanen, G. P. Amminger, S. Ruhrmann, F. Schultze-Lutter, J. Klosterkotter, P. Fusar Poli, A. R. Yung, M. Berk and P. D. McGorry

DOI: 10.2174/138161212799316226

Neurocognition in the Psychosis Risk Syndrome: A Quantitative and Qualitative Review

, 18(4): 399 - 415

Anthony J. Giuliano, Huijun Li, Raquelle I. Mesholam-Gately, Shannon M. Sorenson, Kristen A. Woodberry and Larry J. Seidman

DOI: 10.2174/138161212799316019

Relationship Between Gyrification and Functional Connectivity of the Prefrontal Cortex in Subjects at High Genetic Risk of Schizophrenia

, 18(4): 434 - 442

Maria R. Dauvermann, Prerona Mukherjee, William T. Moorhead, Andrew C. Stanfield, Paolo Fusar-Poli, Stephen M. Lawrie and Heather C. Whalley

DOI: 10.2174/138161212799316235

Cingulate Volume Abnormalities in Emerging Psychosis

, 18(4): 495 - 504

Michel Rothlisberger, Anita Riecher-Rossler, Jacqueline Aston, Paolo Fusar-Poli, Ernst-Wilhelm Radu and Stefan Borgwardt

DOI: 10.2174/138161212799316316

Biochemical Markers of Impending Psychosis

, 18(4): 505 - 509

Enzo Emanuele, Valentina Martinelli, Vera Abbiati, Paolo Fusar-Poli and Pierluigi Politi

DOI: 10.2174/138161212799316000

Genetic Vulnerability to Psychosis and Cortical Function: Epistatic Effects between DAAO and G72

, 18(4): 510 - 517

Mechelli Andrea, Fusar-Poli Paolo, Prata Diana, Papagni Sergio Alessandro, Tognin Stefania, Kambeitz Joseph, Fu Cynthia, Picchioni Marco, Walshe Muriel, Toulopoulou Timothea, Bramon Elvira, Murray Robin and McGuire Philip

DOI: 10.2174/138161212799316037

Stress and the Prodromal Phase of Psychosis

, 18(4): 527 - 533

Carrie W. Holtzman, Daniel I. Shapiro, Hanan D. Trotman and Elaine F. Walker

DOI: 10.2174/138161212799316280

Pharmacological Prevention and Treatment in Clinical At-Risk States for Psychosis

, 18(4): 550 - 557

Stephan Ruhrmann, Joachim Klosterkotter, Mitja Bodatsch, Andreas Bechdolf, Benno Graf Schimmelmann, Alexandra Nikolaides, Desiree Hilboll and Frauke Schultze-Lutter

DOI: 10.2174/138161212799316172

Neuroprotective Effects of Low-dose Lithium in Individuals at Ultra-high Risk for Psychosis. A Longitudinal MRI/MRS Study

, 18(4): 570 - 575

Gregor E. Berger, Stephen J. Wood, Margaret Ross, Clare A. Hamer, R. Mark Wellard, Gaby Pell, Lisa Phillips, Barnaby Nelson, G. Paul Amminger, Alison R. Yung, Graeme Jackson, Dennis Velakoulis, Christos Pantelis, Husseini Manji and Patrick D McGorry

DOI: 10.2174/138161212799316163

Polyunsaturated Fatty Acids in Emerging Psychosis

, 18(4): 576 - 591

Nilufar Mossaheb, Monika Schloegelhofer, Miriam R. Schaefer, Paolo Fusar-Poli, Stefan Smesny, Pat McGorry, Gregor Berger and G. Paul Amminger

DOI: 10.2174/138161212799316055

Ethical Implications for Clinical Practice and Future Research in “At Risk” Individuals

, 18(4): 606 - 612

Fiza Singh, Heline Mirzakhanian, Paolo Fusar-Poli, Camilo de la Fuente-Sandoval and Kristin S. Cadenhead

DOI: 10.2174/138161212799316262


Alessandro Antonelli
(12,288 citations)
Department of Clinical and Experimental Medicine
Laboratory of Primary Human Cells
University of Pisa
View Full Editorial Board

Nobel Laureate on Editorial Board

Andrew V. Schally

COPE Compliant

Cope Logo

Journal History

Current Pharmaceutical Design was introduced in 1995. Prof. Alessandro Antonelli serves as the Editor-in-Chief of the journal.



Related Journals

Related eBooks

eBooks Catalog